Blend to Limit Oxygen in ECMO: A Randomised Controlled Registry Trial
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.
Also called NCT03841084
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 300 participants
- Sponsor
- Australian and New Zealand Intensive Care Research Centre
- Registry
-
NCT03841084
-
- Other papers using this trial's data
- Conservative or liberal oxygen targets in patients on venoarterial extracorporeal membrane oxygenation
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Australia
- Registry status
- Completed
Technical summary
Registry record NCT03841084. Randomized; no masking; primary purpose treatment. Start 2019-09-18 (actual); primary completion 2023-06-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Blend to Limit Oxygen in ECMO: A Randomised Controlled Registry Trial
- Acronym
- BLENDER
- Condition
- Cardiac Failure
- Condition
- Critical Illness
- Intervention (Drug)
- Oxygen
- Lead sponsor
- Australian and New Zealand Intensive Care Research Centre
Record details
- Record id
cardio:ct-nct03841084- Content hash
0299a0522fc1761dae645f2ccb6e7e7ad9d7bfe6fb51e6a64324c652d29ec755